After proteins of interest were identified, we switched to the detailed line chart views to measure SOX10 (a tumor marker) and CD3D (immune marker), HLAA (marking cell membrane), along with inhibitory pathway PDL1-PD1. Here, CD3D is linked to neoplasm.